Article

jdsupra.comjdsupra.com on 2019-01-02 20:56

Year in Review: Top U.S. Biosimilars-Related Regulatory Developments of 2018

Here are our picks for the most significant U.S. regulatory developments related to biosimilars in 2018: 1. FDA Releases Biosimilars ...

Related news